Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Lacutamab (Anti-KIR3DL2 / CD158k) For research use only.
Not for use in humans.

Lacutamab (Anti-KIR3DL2 / CD158k)

Synonyms: IPH 4102

Lacutamab (Anti-KIR3DL2 / CD158k) is a humanized monoclonal antibody against the immune receptor human killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 (KIR3DL2), with potential immunomodulating and antineoplastic activities. MW: 150 kD.

Lacutamab (Anti-KIR3DL2 / CD158k)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Lacutamab (Anti-KIR3DL2 / CD158k) is a humanized monoclonal antibody against the immune receptor human killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 (KIR3DL2), with potential immunomodulating and antineoplastic activities. MW: 150 kD.

Product Details

CAS No.  2187368-16-5
Molecular Weight 150 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lacutamab (Anti-KIR3DL2 / CD158k) | Lacutamab (Anti-KIR3DL2 / CD158k) supplier | purchase Lacutamab (Anti-KIR3DL2 / CD158k) | Lacutamab (Anti-KIR3DL2 / CD158k) cost | Lacutamab (Anti-KIR3DL2 / CD158k) manufacturer | order Lacutamab (Anti-KIR3DL2 / CD158k) | Lacutamab (Anti-KIR3DL2 / CD158k) distributor